247 related articles for article (PubMed ID: 30721268)
1. The Apparent Diffusion Coefficient (ADC) is a useful biomarker in predicting metastatic colon cancer using the ADC-value of the primary tumor.
Nerad E; Delli Pizzi A; Lambregts DMJ; Maas M; Wadhwani S; Bakers FCH; van den Bosch HCM; Beets-Tan RGH; Lahaye MJ
PLoS One; 2019; 14(2):e0211830. PubMed ID: 30721268
[TBL] [Abstract][Full Text] [Related]
2. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
[TBL] [Abstract][Full Text] [Related]
3. Improving lymph node characterization in staging malignant lymphoma using first-order ADC texture analysis from whole-body diffusion-weighted MRI.
De Paepe KN; De Keyzer F; Wolter P; Bechter O; Dierickx D; Janssens A; Verhoef G; Oyen R; Vandecaveye V
J Magn Reson Imaging; 2018 Oct; 48(4):897-906. PubMed ID: 29656584
[TBL] [Abstract][Full Text] [Related]
4. Histogram analysis of apparent diffusion coefficient map of diffusion-weighted MRI in endometrial cancer: a preliminary correlation study with histological grade.
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Dec; 55(10):1270-7. PubMed ID: 24316663
[TBL] [Abstract][Full Text] [Related]
5. Estimation of colon cancer grade and metastatic lymph node involvement using DWI/ADC sequences.
Marija C; Kresimir D; Ognjen B; Iva P; Nenad K; Matija B
Acta Radiol; 2023 Apr; 64(4):1341-1346. PubMed ID: 36197524
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of diffusion-weighted magnetic resonance imaging: differentiation of benign and malignant lymph nodes in different regions of the body.
Seber T; Caglar E; Uylar T; Karaman N; Aktas E; Aribas BK
Clin Imaging; 2015; 39(5):856-62. PubMed ID: 26091745
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Neck Lymph Nodes in Head and Neck Cancer: A Sample of Iranian Patient.
Alamolhoda F; Faeghi F; Bakhshandeh M; Ahmadi A; Sanei Taheri M; Aabbasi S
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1789-1795. PubMed ID: 31244301
[TBL] [Abstract][Full Text] [Related]
8. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
[TBL] [Abstract][Full Text] [Related]
9. Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?
van Heeswijk MM; Lambregts DMJ; Maas M; Lahaye MJ; Ayas Z; Slenter JMGM; Beets GL; Bakers FCH; Beets-Tan RGH
Abdom Radiol (NY); 2017 Jun; 42(6):1627-1636. PubMed ID: 28160039
[TBL] [Abstract][Full Text] [Related]
10. ADC Histogram Analysis of Cervical Cancer Aids Detecting Lymphatic Metastases-a Preliminary Study.
Schob S; Meyer HJ; Pazaitis N; Schramm D; Bremicker K; Exner M; Höhn AK; Garnov N; Surov A
Mol Imaging Biol; 2017 Dec; 19(6):953-962. PubMed ID: 28315203
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted imaging in the detection of lymph node metastasis in colorectal cancer.
Yasui O; Sato M; Kamada A
Tohoku J Exp Med; 2009 Jul; 218(3):177-83. PubMed ID: 19561387
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient ratio between axillary lymph node with primary tumor to detect nodal metastasis in breast cancer patients.
Luo N; Su D; Jin G; Liu L; Zhu X; Xie D; Liu Y
J Magn Reson Imaging; 2013 Oct; 38(4):824-8. PubMed ID: 23440958
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy.
Lista F; Andrés G; Cáceres F; Ramón de Fata F; Rodríguez-Barbero JM; Angulo JC
Actas Urol Esp; 2013; 37(7):419-24. PubMed ID: 23773823
[TBL] [Abstract][Full Text] [Related]
15. Early-stage invasive ductal carcinoma: Association of tumor apparent diffusion coefficient values with axillary lymph node metastasis.
Kim JY; Seo HB; Park S; Moon JI; Lee JW; Lee NK; Lee SW; Bae YT
Eur J Radiol; 2015 Nov; 84(11):2137-43. PubMed ID: 26318821
[TBL] [Abstract][Full Text] [Related]
16. Histogram analysis of apparent diffusion coefficient maps for the differentiation between lymphoma and metastatic lymph nodes of squamous cell carcinoma in head and neck region.
Wang YJ; Xu XQ; Hu H; Su GY; Shen J; Shi HB; Wu FY
Acta Radiol; 2018 Jun; 59(6):672-680. PubMed ID: 28870086
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of diffusion-weighted (DW) MRI with background signal suppression (MR-DWIBS) in diagnosis of mediastinal lymph node metastasis of nonsmall-cell lung cancer (NSCLC).
Xu L; Tian J; Liu Y; Li C
J Magn Reson Imaging; 2014 Jul; 40(1):200-5. PubMed ID: 24923480
[TBL] [Abstract][Full Text] [Related]
18. Whole-tumor histogram analysis of apparent diffusion coefficient in differentiating intracranial solitary fibrous tumor/hemangiopericytoma from angiomatous meningioma.
He W; Xiao X; Li X; Guo Y; Guo L; Liu X; Xu Y; Zhou J; Wu Y
Eur J Radiol; 2019 Mar; 112():186-191. PubMed ID: 30777209
[TBL] [Abstract][Full Text] [Related]
19. Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
Tsuchiya N; Doai M; Usuda K; Uramoto H; Tonami H
PLoS One; 2017; 12(2):e0172433. PubMed ID: 28207858
[TBL] [Abstract][Full Text] [Related]
20. Predicting metastasis in clinically negative axillary lymph nodes with minimum apparent diffusion coefficient value in luminal A-like breast cancer.
Kato F; Kudo K; Yamashita H; Baba M; Shimizu A; Oyama-Manabe N; Kinoshita R; Li R; Shirato H
Breast Cancer; 2019 Sep; 26(5):628-636. PubMed ID: 30937834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
